Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats

Pharmacological Reports

Volumn 59, Issue 3, 2007, Pages 339-348

  Ramesh, Balakrishnan ^a   Pugalendi, Kodukkur V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diabetes; Membrane bound ATPases; Streptozotocin; Umbelliferone

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIMETHYL SULFOXIDE; GLIBENCLAMIDE; GLUCOSE; INSULIN; STREPTOZOCIN; UMBELLIFERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APPLE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FRUIT; GLYCEMIC CONTROL; HEART; KIDNEY PARENCHYMA; LIPID PEROXIDATION; LIVER PARENCHYMA; MALE; MEMBRANE BINDING; NONHUMAN; RAT; SOUR ORANGE; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

EID: 34548131589     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. +-pumping activity in erythrocytes from IDDM and NIDDM subjects. Diabetes 1989, 38, 825-831.
2. Baynes JW, Thorpe SR: The role of oxidative stress in diabetic complications. Curr Opin Endocrinol, 1996, 3, 277-284.
3. Bonting SL: Membrane and ion transport. In: Enterscience. Ed. Bittar C, Willey EE, Vol. 1, London, 1970, 25-28.
4. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care, 1992, 15, 1835-1843.
5. Burgi W, Briner M, Franken N, Kessler AC: One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem, 1988, 21, 311-314.
6. Chakraborty R, Rajagopalan R: Diabetes and insulin resistance associated disorders: disease and the therapy. Curr Sci, 2002, 83, 1533-1538.
7. Clausen T, Everts ME: Regulation of the Na, K-pump in skeletal muscle. Kidney Int, 1989, 35, 1-13.
8. Evans WH: Membrane adenosine triphosphatase of E. coli activation by calcium ions inhibition by monovalent cations. J Bacteriol, 1969, 100, 914.
9. Fiske GH, Subbarrow Y. The colorimetric determination of phosphorus. J Biol Chem 1925, 66, 375-400.
10. 2+-transport in alloxan-induced diabetes in rat, Diabetes. Res Clin Pract, 996, 31, S73-S77.
11. 2+-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro. Diabetes, 1990, 39, 707-711.
12. Greene DA, Lattimer SA: Biochemical alterations and complications in diabetes. Clin Chem, 1986, 32, B42-B47.
13. + pump activity by insulin and nitric oxide in rabbit aorti. Am J Physiol, 1996, 270, H1287-H1293.
14. 2+-ATPase from erythrocyte membranes. Biochim Biophys Acta, 1983,728, 281-289.
15. Hope-Gill HF, Nanda V: Stimulation of calcium ATPase by insulin, glucagon, cyclic AMP and cyclic GMP in triton X-100 extracts of purified rat liver plasma membrane. Horm Metab Res, 1979, 11, 698-700.
16. Hoult JRS, Paya M: Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential. Gen Pharmacol, 1996, 27, 713-722.
17. 2+-ATPase in high glucose-treated human erythrocytes. Free Radic Biol Med, 2000, 29, 1122-1128.
18. Jain SK, Palmer M: The effect of oxygen radicals' metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med, 1997, 22, 593-596.
19. Jeffcoate SL: Diabetes control and complications: the role of glycated hemoglobin, 25 years on. Diabet Med, 2004, 21, 657-665.
20. Jiang ZY, Hunt JV, Wolff SP: Detection of lipid hydroperoxides using the "Fox method". Anal Biochem, 1992, 202, 384-389.
21. Kameswararao B, Kesavulu MM, Apparao C: Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats. Fitoterapia, 2003, 74, 7-13.
22. +)-ATPase activity in diabetic patients. Clin Biochem, 1997, 30, 177-182.
23. + pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat. Diabetes, 1987, 36, 842-848.
24. Klein RA: The detection of oxidation in liposome preparation. Biochim Biophys Acta, 1979, 210, 486-489.
25. Knowles AF, Li C: Molecular cloning and characterization of expressed human ecto-nucleoside triphosphate diphosphohydrolase 8 (E-NTPDase 8) and its soluble extracellular domain. Biochemistry, 2006, 45, 7323-7333.
26. +)-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus. Endocrine, 2003, 21, 273-278.
27. Kuwahara Y, Yanagishita T, Konno N, Katagiri T: Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzyme in diabetic rat heart. Basic Res Cardiol, 1997, 92, 214-222.
28. La Celle PR, Kirkpatrick FH: Determinants of erythrocyte membrane elasticity. In: Erythrocyte Structure and Function. Ed. Brewer G Jr, Liss AR, New York, 1975, 535.
29. Levy J, Gavin III JR, Sower JR: Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med, 1994, 94, 260-273.
30. Malecki TM, Klupa T: Type 2 diabetes mellitus: from genes to disease. Pharmacol Rep, 2005, 57, 20-32.
31. Marles RJ, Farnsworth N: Antidiabetic plants and their active constituents: an update. Prof J Bot Med, 1996, 3, 85-135.
32. Matkovics S, Kotorman M, Varga IS, Hai DQ, Roman F, Novak Z: Proantioxidant and filtration changes in blood of type 1 diabetic patient. Acta Physiol. Hung, 1997-98, 85, 99-106.
33. McDonough AA, Geering K, Farley RA: The sodium pump needs its β-subunit. FASEB J, 1990,4, 1598-1605.
34. Muczynski KA, Stahl WL: Incorporation of dansylated phospholipids and dehydroergosterol into membranes using a phospholipid exchange protein. Biochemistry-US, 1983, 22, 6037-6048.
35. Niechaus WG, Samuelson B: Formation of MDA from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem, 1968, 6, 126-130.
36. Ohnishi T, Suzuki T, Suzuki Y, Orzawa K. A comparative study of plasma membrane magnesium ion ATPase activity in normal, regenerating and malignant cells. Biochim Biophys Acta, 1982, 684, 67-74.
37. Parmar C, Kaushal MK: Aegle marmelos. In: Wild Fruits. Kalyani Publishers, New Delhi, India, 1982, 1-5.
38. Raj HG, Parmar VS, Jain SC: Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part II: Mechanism-based inhibition of rat liver microsome-mediated aflatoxih B1-DNA binding by the candidate antimutagen 7, 8-diacetoxy-4-methylcoumarin. Bioorg Med Chem, 1998, 6, 1895-1904.
39. Rajeswari P, Natarajan R, Nadler JL, Kumar D, Kalra VK: Glucose induces lipid peroxidation and inactivation of membrane associated ion-transport enzymes in human erythrocytes in vivo and in vitro, J Cell Physiol, 1991, 149, 100-109.
40. Ramesh B, Pugalendi KV: Antioxidant role of umbelliferone in STZ-diabetic rats. Life Sci, 2006, 79, 306-310.
41. Ramesh B, Pugalendi KV: Antihyperglycaemic effect of umbelliferone in STZ-diabetic rats. J Med Food, 2006, 9, 562-566.
42. Ramesh B, Pugalendi KV: Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats. Yale J Biol Med, 2005, 78, 189-196.
43. Ramesh B, Pugalendi KV: Effect of umbelliferone on cellular redox status in STZ-diabetic rats. World Wide Web J Biol, 2005, 9-1.
44. Ramesh B, Pugalendi KV: Impact of umbelliferone on erythrocyte redox status in STZ-diabetic rats. Yale J Biol Med, 2005, 78, 133-140.
45. Ramesh B, Pugalendi KV: Influence of umbelliferone on glycoprotein components in diabetic rats. Toxicol Mech Method, 2000, 17, 1-7.
46. Rizvi SI, Abu Zeid M: Modulation of erythrocyte membrane (Na+/K+)-ATPase activity by insulin in normal and type 2 diabetic patients. Evaluation of insulin-like role of epicatechin. Med Sci Res, 1998, 26, 245-247.
47. Sabbadini RA, Dahms AS: Biochemical properties of isolated transverse tubular membranes. J Bioenerg Biomembr, 1989, 21, 163-213.
48. +-ATPase. Free Radic Biol Med, 1996, 20, 215-223.
49. +)-ATPase in diabetes mellitus. Biochem Biophys Res Commun, 1987, 146, 179-186.
50. +)-ATPase. Biochim Biophys Acta, 1989, 988, 185-220.
51. Trinder P: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Clin Biochem, 1969, 6, 24-27.
52. +)-ATPase in rats. Pharmacol Res, 2001, 44, 95-98.
53. +)-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect on insulin treatment. Diabetologia, 1997, 40, 1255-1262.
54. Watala C: Altered structural and dynamic properties of blood cell membranes in diabetes mellitus. Diabet Med, 1993, 10, 13-20.
55. Wu FJ, Sheu SJ: Analysis and processing of Chinese herbal drugs: The study of Fructus aurantii Immaturus (Chin.). Chin Pharm J, 1992, 44, 257-263.
56. Yagihashi S: Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev, 1995, 11, 193-225.